Channel Therapeutics Corp. Files Q1 2025 10-Q
Ticker: PTHS · Form: 10-Q · Filed: May 13, 2025 · CIK: 1919246
| Field | Detail |
|---|---|
| Company | Channel Therapeutics Corp (PTHS) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, biotech
TL;DR
Channel Therapeutics filed its Q1 2025 10-Q. All systems go.
AI Summary
Channel Therapeutics Corp. filed its 10-Q for the period ending March 31, 2025. The company, formerly Chromocell Therapeutics Corp, is incorporated in Nevada and operates in the biological products sector. Its principal executive offices are located at 685 US Highway One, North Brunswick, NJ.
Why It Matters
This filing provides a quarterly update on Channel Therapeutics Corp.'s financial health and operational status, crucial for investors and stakeholders to assess the company's performance.
Risk Assessment
Risk Level: low — The filing is a routine quarterly report and does not contain immediate, high-impact news.
Key Numbers
- 0.32 — Common Stock Price (Reported value for the period)
- 0.55 — Common Stock Price (Reported value for the period)
Key Players & Entities
- Channel Therapeutics Corp. (company) — Filer of the 10-Q
- Chromocell Therapeutics Corp (company) — Former name of Channel Therapeutics Corp.
- 20250331 (date) — End of reporting period
- 20250513 (date) — Filing date
- 685 US Highway One, North Brunswick, NJ (location) — Business and mailing address
FAQ
What is the company's primary business activity?
Channel Therapeutics Corp. is in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) sector, SIC code [2836].
When was the company formerly known as Chromocell Therapeutics Corp.?
The date of the name change from Chromocell Therapeutics Corp. to Channel Therapeutics Corp. was March 23, 2022.
What is the fiscal year end for Channel Therapeutics Corp.?
The fiscal year end for Channel Therapeutics Corp. is December 31.
What is the SEC file number for Channel Therapeutics Corp.?
The SEC file number is 001-41964.
What are the reported stock prices for the period?
The filing reports a common stock price of $0.32 and $0.55 for the period.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Channel Therapeutics Corp (PTHS).